|
2024
|
Invention
|
Gip activity modulators and orthostatic intolerance. The present disclosure provided glucose-depe... |
|
2022
|
Invention
|
Treatment of obesity and obesity-related disorders.
The present invention relates to a glucose-d... |
|
|
Invention
|
Treatment of obesity and obesity-related disorders. The present invention relates to a glucose-de... |
|
2020
|
Invention
|
Optimized gip peptide analogues.
Disclosed are glucose-dependent insulinotropic peptide (GIP) -d... |
|
|
Invention
|
Optimized gip peptide analogues. Disclosed are glucose-dependent insulinotropic peptide (GIP) -de... |
|
2019
|
Invention
|
Modified gip peptide analogues. Disclosed are glucose-dependent insulinotropic peptide (GIP)-deri... |
|
|
Invention
|
Modified gip peptide analogues. Disclosed are glucose-dependent insulinotropic peptide (GIP) -der... |
